Douglas Burtrum

2.1k total citations
18 papers, 1.7k citations indexed

About

Douglas Burtrum is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Douglas Burtrum has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 6 papers in Immunology. Recurrent topics in Douglas Burtrum's work include Glycosylation and Glycoproteins Research (5 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). Douglas Burtrum is often cited by papers focused on Glycosylation and Glycoproteins Research (5 papers), T-cell and B-cell Immunology (5 papers) and Immune Cell Function and Interaction (4 papers). Douglas Burtrum collaborates with scholars based in United States. Douglas Burtrum's co-authors include Howard T. Petrie, Svetlana M. Mazel, Faye S. Silverstein, Jerzy P. Szaflarski, Dale L. Ludwig, Ferenc Livák, Michelle R. Tourigny, Larry Witte, Peter Böhlen and Zhenping Zhu and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Douglas Burtrum

17 papers receiving 1.6k citations

Peers

Douglas Burtrum
Comparison fields: 5 of 91
  • Molecular Biology 806
  • Immunology 550
  • Oncology 439
  • Endocrinology, Diabetes and Metabolism 298
  • Cancer Research 238
Replace Roberta P. Glick with:
Roberta P. Glick United States
Jason Gill Switzerland
Tomoo Ueno Japan
Gerda Ricken Austria
Jerzy Trojan France
V. Poulaki United States
Knut Dietzmann Germany
Ulf Dahl Sweden
Peter Krasnov United States
Jung Oh Kim South Korea
Roberta P. Glick United States View profile →
Citations per field, relative to Douglas Burtrum
Douglas Burtrum · 1×
Citations per year, relative to Douglas Burtrum
Douglas Burtrum · 1×

Countries citing papers authored by Douglas Burtrum

Since Specialization
Citations

This map shows the geographic impact of Douglas Burtrum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Burtrum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Burtrum more than expected).

Fields of papers citing papers by Douglas Burtrum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Burtrum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Burtrum. The network helps show where Douglas Burtrum may publish in the future.

Co-authorship network of co-authors of Douglas Burtrum

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Burtrum. A scholar is included among the top collaborators of Douglas Burtrum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Burtrum. Douglas Burtrum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
# Work Indexed citations
1 1
2 11
3 1
4 65
5 2
6 144
7 45
8 98
9
A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
298
10 38
11 47
12 111
13 251
14 72
15 159
16 239
17 53
18 20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026